LOADING

Type to search

Category: BioTech

new-webinars:-simple-signaling-reporter-assays-&-reducing-attrition-from-drug-induced-liver-injury
gilead-gains-foothold-in-solid-tumors-with-$375m,-10-year-arcus-bio-pact
gilead-pens-$2b-arcus-pact-for-immuno-oncology-targets-of-the-past-and-future
ngos-slam-‘extremely-dubious-priorities’-of-eu-r&d-program
startup-targets-glioblastoma-tumors-with-car-t-therapy
the-money-keeps-coming-for-eli-lilly-covid-19-partner-abcellera-with-$105m-round
merck-outlines-covid-19-ambitions-with-buyout-deal,-collaborations
insitro-adds-$143m-to-fuel-machine-learning-driven-drug-development
viacyte-adds-$27m-to-move-ahead-trio-of-stem-cell-diabetes-treatments
argenx’s-autoimmune-phase-3-hits-goals,-teeing-up-fda-filing